AQSTAquestive Therapeutics, Inc.

$427M

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$23M+42.4% YoY

Gross Profit

$18M75.9% margin

Operating Income

$5M22.7% margin

Net Income

$4M17.5% margin

EPS (Diluted)

$0.20

QoQ Revenue Growth

+92.0%

Cash Flow

Operating Cash Flow

$785,000

Free Cash Flow

$526,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$46M

Total Liabilities

$69M

Stockholders' Equity

-$23M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$16M	+42.4%
Gross Profit	$18M	$12M	+45.1%
Operating Income	$5M	$781,000	+579.3%
Net Income	$4M	-$1M	+381.3%

AQST Q1 2018 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena